Skip to main content
. 2018 Sep 15;11:52–61. doi: 10.1016/j.omto.2018.09.001

Figure 3.

Figure 3

Relapse of ERMS Tumors following NRAS Targeting

(A) Change in tumor volume over time in NRAS-targeted tumors compared with controls. (B) Example of common NRAS mutations found in relapsed tumor xenografts and an isolated NRAS-targeting-resistant clone.